Angiofibroma
Showing 1 - 19 of 19
Juvenile Nasopharyngeal Angiofibroma Trial in Moscow (Sirolimus)
Recruiting
- Juvenile Nasopharyngeal Angiofibroma
-
Moscow, Russian FederationResearch Institute of Pediatric Hematology, Oncology and Immunol
Sep 19, 2022
Facial Angiofibroma, Tuberous Sclerosis Trial in Worldwide (rapamycin, )
Completed
- Facial Angiofibroma
- Tuberous Sclerosis
- rapamycin
- placebo
-
Phoenix, Arizona
- +16 more
Jul 26, 2022
Biomarkers for Tuberous Sclerosis Complex (BioTuScCom)
Active, not recruiting
- Hypomelanotic Macules
- +8 more
-
Tirana, Albania
- +7 more
Mar 23, 2022
Angiofibroma of Face, Tuberous Sclerosis Trial in China, United States (Sirolimus 0.2%, Sirolimus 0.4%, Placebo ointment)
Recruiting
- Angiofibroma of Face
- Tuberous Sclerosis
- Sirolimus 0.2%
- +2 more
-
Phoenix, Arizona
- +7 more
Feb 2, 2022
Squamous Cell Carcinoma of the Head and Neck, Nasopharyngeal Carcinoma, Salivary Gland Cancer Trial in Saint Louis (stereotactic
Completed
- Squamous Cell Carcinoma of the Head and Neck
- +7 more
- stereotactic body radiotherapy
- Stereotactic body radiotherapy
-
Saint Louis, MissouriSt. John's Mercy Medical Center
Mar 28, 2020
Angiofibromas, Tuberous Sclerosis Trial in Australia, United States (Placebo, Rapamycin)
Completed
- Angiofibromas
- Tuberous Sclerosis
- Placebo
- Rapamycin
-
Birmingham, Alabama
- +9 more
Sep 30, 2020
Tuberous Sclerosis Complex Trial in Japan (NPC-12Y gel, NPC-12Y gel)
Recruiting
- Tuberous Sclerosis Complex
- NPC-12Y gel
- NPC-12Y placebo gel
-
Toyoake, Aichi, Japan
- +4 more
Aug 8, 2022
Tuberous Sclerosis, Angiofibroma, Hypomelanotic Macule Trial in Suita, Osaka (NPC-12G gel)
Completed
- Tuberous Sclerosis
- +3 more
- NPC-12G gel
-
Suita, Osaka, JapanGraduate School of Medicine, Osaka University
Feb 18, 2019
Tuberous Sclerosis, Lymphangioleiomyomatosis Trial in Canada, United States (procedure, genetic, other)
Recruiting
- Tuberous Sclerosis
- Lymphangioleiomyomatosis
- Phlebotomy
- +3 more
-
Birmingham, Alabama
- +22 more
Jan 6, 2023
Dengue, Dengue Fever, Dengue Hemorrhagic Fever Trial in Worldwide (Live, attenuated, dengue serotype 1, 2, 3, 4 virus, Placebo:
Completed
- Dengue
- +2 more
- Live, attenuated, dengue serotype 1, 2, 3, 4 virus
- Placebo: Sodium chloride (NaCl) 0.9%
-
Denpasar, Bali, Indonesia
- +11 more
Mar 10, 2022
Tuberous Sclerosis, Angiofibroma, Hypomelanotic Macule Trial in Suita, Osaka (NPC-12G gel, Placebo gel)
Completed
- Tuberous Sclerosis
- +3 more
- NPC-12G gel
- Placebo gel
-
Suita, Osaka, JapanGraduate School of Medicine, Osaka University
Feb 1, 2017
Facial Angiofibroma Trial in Memphis (Rapamune)
Completed
- Facial Angiofibroma
-
Memphis, TennesseeLeBonheur Children's Hospital
Aug 17, 2016
Food Allergy Trial in New York (Partially Hydrolyzed Whey formula)
Completed
- Food Allergy
- Partially Hydrolyzed Whey formula
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Dec 6, 2016
Fabry Disease Trial in Copenhagen (Enzyme replacement)
Completed
- Fabry Disease
- Enzyme replacement
-
Copenhagen, Capital region, Denmark
- +1 more
Oct 26, 2014
Hyperpigmentation Trial in Boston (Nu Skin Product, Cosmetic instrument, Tretinoin cream 0.05)
Completed
- Hyperpigmentation
- Nu Skin Product
- +3 more
-
Boston, MassachusettsMassachusetts General Hospital
Oct 30, 2014
Tuberous Sclerosis, Neurofibromatoses, Angiofibroma Trial in Houston (Skincerity, Skincerity plus sirolimus/rapamycin,
Completed
- Tuberous Sclerosis
- +3 more
- Skincerity
- +2 more
-
Houston, TexasThe University of Texas Health Science Center
Feb 24, 2012